Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

10.99
Data as of Jul 29
 -0.05 / -0.45%
Today’s Change
3.00
Today|||52-Week Range
21.00
+6.60%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$116.9M

Company Description

Tonix Pharmaceuticals Holding Corp. is a pharmaceutical company. It is focused on developing new pharmaceutical products that are safer and more effective than widely prescribed central nervous system drugs in large and growing markets. It products include TNX-102 SL and TNX-102 SL. Tonix Pharmaceuticals Holding was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.

Contact Information

Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue
New York New York 10022
P:(212) 980-9155
Investor Relations:

Employees

Shareholders

Individual stakeholders7.53%
Mutual fund holders5.73%
Other institutional25.44%

Top Executives

Seth LedermanChairman, President & Chief Executive Officer
Leland J. GershellChief Financial Officer & Treasurer
Gregory M. SullivanChief Medical Officer
Bruce L. DaughertySecretary, Chief Scientific Officer & Controller
Jessica E. EdgarSenior Vice President-Finance

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.